glp-1/gip/glucagon receptor agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Targeting GLP-1, GIP & GCG

Heimbrger SM, Bergmann NC, Augustin R, Gasbjerg LS, Christensen MB, Knop FK

Key References Blher M, Rosenstock J, Hoefler J, et al

Since protein is essential for muscle preservation and growth, inadequate consumption can contribute to muscle breakdown

People have said likely it was the weight loss but I believed it was the GLP-1

*Disclaimer: Major Players sorted in no particular order Recent Industry Developments December 2025: WHO recommended GLP-1 receptor agonists as part of comprehensive adult-obesity care, citing cardio-metabolic benefits

Conclusion: When Careers Are on the Line, Testing Depth Matters The 2026 WADA Prohibited List taking effect represents another evolution in anti-doping standards, with new substances explicitly prohibited and others being monitored for potential misuse